Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas-ko ikertzaileekin lankidetzan egindako argitalpenak (12)

2024

  1. A nonlinear meccano for Alzheimer's emergence by amyloid β-mediated glutamatergic hyperactivity

    Neurobiology of Disease, Vol. 194

  2. Assessment of the Correlation and Diagnostic Accuracy between Cerebrospinal Fluid and Plasma Alzheimer’s Disease Biomarkers: A Comparison of the Lumipulse and Simoa Platforms

    International Journal of Molecular Sciences, Vol. 25, Núm. 9

2023

  1. Microglial phagocytosis dysfunction in stroke is driven by energy depletion and induction of autophagy

    Autophagy, Vol. 19, Núm. 7, pp. 1952-1981

2022

  1. A Neuron, Microglia, and Astrocyte Triple Co-culture Model to Study Alzheimer’s Disease

    Frontiers in Aging Neuroscience, Vol. 14

  2. Linking Plasma Amyloid Beta and Neurofilament Light Chain to Intracortical Myelin Content in Cognitively Normal Older Adults

    Frontiers in Aging Neuroscience, Vol. 14

  3. New, Fully Implantable Device for Selective Clearance of CSF-Target Molecules: Proof of Concept in a Murine Model of Alzheimer's Disease

    International journal of molecular sciences, Vol. 23, Núm. 16

  4. Recombinant Integrin β1 Signal Peptide Blocks Gliosis Induced by Aβ Oligomers

    International Journal of Molecular Sciences, Vol. 23, Núm. 10

2021

  1. Longitudinal evaluation of a novel BChE PET tracer as an early in vivo biomarker in the brain of a mouse model for Alzheimer disease

    Theranostics, Vol. 11, Núm. 13, pp. 6542-6559

  2. Polyphenols attenuate mitochondrial dysfunction induced by amyloid peptides

    Mitochondrial Physiology and Vegetal Molecules: Therapeutic Potential of Natural Compounds on Mitochondrial Health (Elsevier), pp. 317-337

  3. Whole blood expression pattern of inflammation and redox genes in mild alzheimer’s disease

    Journal of Inflammation Research, Vol. 14, pp. 6085-6102

2018

  1. Mangiferin and morin attenuate oxidative stress, mitochondrial dysfunction, and neurocytotoxicity, induced by Amyloid Beta Oligomers

    Oxidative Medicine and Cellular Longevity, Vol. 2018

  2. Targeting beta-amyloid at the CSF: A new therapeutic strategy in Alzheimer's disease

    Frontiers in Aging Neuroscience, Vol. 10, Núm. APR